Baraclude Oral Solution
Prescription Required
Product introduction
Entecavir is an antiviral medicine used in the treatment of hepatitis B virus (HBV) infection. It works by inhibiting the replication of the virus, thereby reducing its levels in the body. By suppressing viral replication, it helps to slow down the progression of liver damage.
Baraclude Oral Solution is used in the treatment of HIV infections
Baraclude Oral Solution is used in the treatment of HIV infections
Uses of Baraclude Oral Solution
Benefits of Baraclude Oral Solution
In Chronic hepatitis B virus (HBV) infection
In patients with chronic hepatitis B virus (HBV) infection, Baraclude Oral Solution works by preventing the HBV virus from multiplying in the body. It helps control the infection and makes the immune system work better. This lowers the chances of getting complications and improves the quality of life.
This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HBV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HBV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
Side effects of Baraclude Oral Solution
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Baraclude
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Baraclude Oral Solution
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Baraclude Oral Solution is to be taken empty stomach.
How Baraclude Oral Solution works
Baraclude Oral Solution is an antiviral medication. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Baraclude Oral Solution. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Baraclude Oral Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Baraclude Oral Solution is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Baraclude Oral Solution may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Baraclude Oral Solution should be used with caution in patients with kidney disease. Dose adjustment of Baraclude Oral Solution may be needed. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Baraclude Oral Solution is safe to use in patients with liver disease. No dose adjustment of Baraclude Oral Solution is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- You have been prescribed Baraclude Oral Solution for the treatment of chronic hepatitis B virus (HBV) infection.
- Take it on an empty stomach, at least 2 hours after or before a meal.
- Baraclude Oral Solution may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- You may still develop infections or other illnesses associated with viral infection while taking this medication.
- During treatment and for at least six months after stopping this medicine, regular blood tests are needed to monitor your liver function, level of hepatitis B virus and blood cells in your blood.
Fact Box
Chemical Class
Nucleoside analog
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Action Class
Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
Patient concerns
FAQs
Q. How should Baraclude Oral Solution be taken?
You should take Baraclude Oral Solution exactly as prescribed by your doctor and continue taking it till your doctor tells you to stop. It is usually taken once a day on an empty stomach, at least 2 hours after a meal and at least 2 hours before the next meal. It is advised to take it around the same time every day. If not sure, consult your doctor.
Q. Can Baraclude Oral Solution cause liver problems?
Yes, Baraclude Oral Solution can cause serious liver problems like hepatomegaly (enlargement of the liver) and steatosis (an increased build-up of fat in the liver). It is important to know that hepatomegaly along with steatosis is a serious medical emergency which requires immediate medical attention.
Q. What are the symptoms of serious liver problems?
The symptoms of liver problems include jaundice (a condition in which your skin or the white part of your eyes turns yellow), dark-colored urine, light-colored stools, loss of appetite, nausea and stomach pain. These symptoms are more common in women, overweight patients, or if you have been on Baraclude Oral Solution for a long time. Immediately contact your doctor if you experience any such symptoms.
Q. What is drug resistance? Can I develop drug resistance with Baraclude Oral Solution?
Drug resistance is a state where the medicine which was once effective in treating an infection becomes ineffective. This mainly happens due to the ability acquired by the virus or bacteria to get modified inside the body which affects the overall working of the medicine. Hence, the medicine is no longer able to fight against the virus or bacteria. Generally, drug resistance with Baraclude Oral Solution is more likely to happen if you take less dose than what is recommended.
Q. How long should I take Baraclude Oral Solution?
Do not stop taking entecavir without consulting your doctor. Stopping entecavir before treatment may worsen your hepatitis. This can happen during the first several months after you stop taking entecavir. Take the medicine strictly as advised and do not miss any dose.
Q. What if HIV infection co-exists with HBV infection? Will this affect treatment with Baraclude Oral Solution?
The use of Baraclude Oral Solution is not recommended in HBV patients who are also diagnosed with HIV, until and unless these patients start taking medicines for HIV management. Starting Baraclude Oral Solution in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Baraclude Oral Solution.
Q. Can Baraclude Oral Solution cure hepatitis B?
No, Baraclude Oral Solution does not cure hepatitis B but may improve the condition of the liver. The medicine may help decrease the amount of hepatitis B virus (HBV) present in the body. This is done by limiting the ability of HBV to multiply and further infect new liver cells.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Acosta EP, Flexner C. Antiviral Agents (Nonretroviral). In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1616-617.
- Safrin S. Antiviral Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 869.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 474-75.
- Entecavir. Uxbridge, Middlesex: Bristol-Myers Squibb Pharmaceuticals limited; 2006 [revised 1 Feb. 2019] (online) Available from:
- Entecavir. Princeton, New Jersey: Bristol-Myers Squibb; 2005 [revised Oct. 2012]. [Accessed 31 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 31 Mar. 2019] (online) Available from:
- CiplaMed. Entecavir [Prescribing Information]. [Last Revised: 10/03/2021]. [Accessed 22 Jun. 2023] (online) Available from:
- Entecavir [Prescribing Information]. Waterford, Ireland: EirGen Pharma Ltd.; 2017. [Accessed 22 Jun. 2023] (online) Available from:
Marketer details
Name: BMS India Pvt Ltd
Address: Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present